
For some patients with peripheral artery disease, exercise can be impractical or impossible. Could the glucagon-like peptide-1 (GLP-1) agonists offer new hope for restoring movement and quality of life?
Guest Authors: Minitha Jacob, PharmD and Sherry Laguardia, PharmD, BCACP
Special Guest: Kristin Watson, PharmD, BCCP
Music by Good Talk